Download bronchiectasis registration criteria

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
BRONCHIECTASIS
REGISTRATION CRITERIA : SPECIALIST INITIATION OF TREATMENT AND FOR ANY SIGNIFICANT INCREASES IN DOSAGES OR
ADDITION OF MEDICATION.
PLEASE SEE ACCEPTANCE CRITERIA FOR CO-EXISTING CONDITIONS (FOR EXAMPLE ASTHMA, COPD)
FOR ORAL AND INHALED CORTICOSTEROIDS AND OTHER BRONCHODILATORS, PLEASE SEE REGISTRATION CRITERIA
FOR ASTHMA OR COPD
ANTIBIOTICS TO BE REGISTERED FOR 14 DAYS AS PER ALGORITHM
Drug Class
Active Ingredient
Trade Name
Penicillins
Amoxicillin (Trihydrate) Cap 250 MG
IPCAMOX 250MG CAP
ALLMOX 250MG CAP
AMOXICAP 250MG CAP
AUSTELL-AMOXICILLIN 250MG
XERACIL 250MG CAPS
MOXYMAX 250MG CAP
BETAMOX 250MG CAP
PROMOXIL 250MG CAP
A-LENNON AMOXYCILLIN 250M
MOXYPEN 250MG CAP
MAXCIL 250MG CAP
AMOCILLIN 250MG CAP
MOXAN 250MG CAP
AMOCAS 250MG CAP
MYMOX 250MG CAP
MOXYMAX 250MG CAP
Amoxicillin (Trihydrate) Cap 500 MG
ALLMOX 500MG CAP
XERACIL 500MG CAP
BETAMOX 500MG CAP
MOXYMAX 500MG CAP
MAXCIL 500MG CAP
PROMOXIL 500MG CAP
AMOCILLIN 500MG CAP
MOXYPEN 500MG CAP
RANMOXY 500MG CAP
MOXAN 500MG CAP
Tetracyclines
Doxycycline Hyclate Cap 100 MG
A-LENNON DOXYCYCLINE HCL
CYCLIDOX 100MG CAP
DOXYCYL 100MG CAP
PRIOR TO CHRONIC REGISTRATION, ALL FORMULARY DRUGS ARE SUBJECT TO SCHEME RULES ,MAXIMUM MEDICAL AID PRICE (MMAP),
CLINICAL PROTOCOLS AND CHANGES IN PRODUCTS AND PRICES.